SavedAdd your journal

Journals / ANKEM Dergisi / 2005 / Cilt: 19 - Sayı: 3

The evaluation and management of pediatric febril neutropenia

Pediyatrik febril nötropenide değerlendirme ve yönetim

S. Sema ANAK
Arzu AKÇAY
Pages
154–161
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Prevention and optimum management of infectious complications are critical to the overall success of the cancer therapy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Febrile neutropenia is a common clinical problem in patients receiving cancer treatment.
📊
Key Findings & Data:Prevention and optimum management of infectious complications are critical to the overall success of the cancer therapy.
💡
Conclusion & Impact:This review based on "Guidelines in pediatric febrile neutropenia " and includes definitions, initial evaluation and antibiotic therapy, modification of therapy, duration of antibiotic therapy, me of antiviral drugs, granulocyte transfusions, and colony-stimulating factors.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Ateş · Nötropeni · Çocuk

Abstract

Febrile neutropenia is a common clinical problem in patients receiving cancer treatment. Prevention and optimum management of infectious complications are critical to the overall success of the cancer therapy. This review based on "Guidelines in pediatric febrile neutropenia " and includes definitions, initial evaluation and antibiotic therapy, modification of therapy, duration of antibiotic therapy, me of antiviral drugs, granulocyte transfusions, and colony-stimulating factors.

Özet

Febril nötropeni, kanser tedavisi gören hastalarda sık görülen bir klinik sorundur. Kanser tedavisindeki sağkalım başarısını etkileyen en önemli unsurlardan birisi infeksiyöz komplikasyonların önlenmesi ve tedavisidir. Bu yazının hazırlanmasında "Pediatrikfebril nötropeni klavuzu" esas alınmıştır ve tanımlar, başlangıç değerlendirmesi ve tedavisi, tedavi modifikasyonları, antibiyotik tedavisinin süresi, antiviral ilaçlar, granülosit transfüzyonu ve koloni stimüle eden faktörlerin kullanımı gibi konulara yer verilmiştir.

🔖

Cite This Article

ANAK, S. S., AKÇAY, A. (2005). The evaluation and management of pediatric febril neutropenia. ANKEM Dergisi, Cilt: 19 - Sayı: 3, 154–161. https://ajindex.com/articles/209624

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Adamkiewitcz TV, Lorenzana A, Doyle J et al: Peripheral vs. central blood cultures in patients admitted to a pediatric oncology ward, Pediatr Infect Dis 1999;18:556-8
  2. AddockKA,AkinsRL,Farrington EA: Evaluation ofempiric vancomycin therapy in children with fever and neutropenia, Pharmacotherapy 1999; 19:1315-20
  3. Agaoglu L, Devecioglu O, Anak S et al: Cost-effectiveness of cefepime plus netilmicin or ceftazidime plus amikacin ormeropenemmonotherapy in febrile neutropenic children with malignancy in Turkey, J Chemother 2001;13:281-7
  4. Alexander SW,Walsh TJ, FreifeldAG, Pizzo PA: Infectious complications in pediatric cancer patients, “Pizzo PA, Poplack DG (eds): Principles and Practice of PediatricOncology, 4th ed.” kitabında s.1239-83, Lippincott Williams and Wilkins, Philadelphia (2002)
  5. Allen U, Smith CR, Prober CG: The value of skin biopsies in febrile, neutropenic, immunocompromised children,Am J Dis Child 1986;140: 459-61
  6. Baorto EP,Aquino VM, Mullen CAet al: Clinical parameters associated with low bacteremia risk in 1100 pediatric oncology patients with fever and neutropenia, Cancer 2001;92:909-13
  7. Caillot D, Cassasnovas O, Bernard A et al: Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thorasic computed tomographic scan and surgery, J ClinOncol 1997;15: 139-47
  8. Cometta A, Calandra F, Gaya H et al: Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer, Antimicrob Agents Chemother 1996;40:1108-15
  9. Crokaert F: Febrile neutropenia in children, Int J AntimicrobialAgents 2000;16:173-6
  10. Düzova A, Kutluk T, Kanra G et al: Monotherapy with meropenem versus combination therapy with piperacillin plus amikacin as empiric therapy for neutropenic fever in children with lymphoma and solid tumors, Turk J Pediatr 2001;13:105-9
  11. Engel A, Steinbach G, Kern P et al: Diagnostic value of procalcitonin serum levels in neutropenic patients with fever: Comparison with interleukin-8, Scand J Infect Dis 2001;32:832-5
  12. ForbesBA, SahmDF,WeissfeldAS:Bailey-Scott’sDiagnosticMicrobiology, 11th ed., Mosby, St. Louis (2002)
  13. FreifeldAG,Walsh TJ, Pizzo PA: Infectious complications in the pediatric cancer patients, “Pizzo PA, Poplack DG (eds): Principles and Practice of Pediatric Oncology, 3rd ed.” kitabında s.1069-95, JP Lippincott, Philadelphia (1997)
  14. Gözdaşoğlu S, Ertem M, Büyükkeçeci Z et al: